Search results for "Glycerylphosphorylcholine"

showing 5 items of 5 documents

Glycerophosphocholine is elevated in cerebrospinal fluid of Alzheimer patients.

2003

Experimental and clinical studies give evidence for breakdown of membrane phospholipids during neurodegeneration. In the present study, we measured the levels of glycerophosphocholine (GPCh), phosphocholine (PCh), and choline, that is, water-soluble metabolites of phosphatidylcholine (PtdCho), in human cerebrospinal fluid (CSF). Among 30 cognitively normal patients the average CSF levels of GPCh, phosphocholine and choline were 3.64, 1.28, and 1.93 microM, respectively; metabolite levels did not change with increasing age. When compared with age-matched controls, patients with Alzheimer's disease had elevated levels of all choline metabolites: GPCh was significantly increased by 76% (P<0.01…

AdultMalemedicine.medical_specialtyAgingAdolescentMetabolitePhosphorylcholineCholinechemistry.chemical_compoundPhospholipase A2Cerebrospinal fluidAlzheimer DiseasePhosphatidylcholineInternal medicinemedicineCholineHumansVascular dementiaPhosphocholineAgedAged 80 and overbiologyPhosphorylcholineGeneral NeuroscienceDementia VascularAge FactorsMiddle Agedmedicine.diseaseGlycerylphosphorylcholineEndocrinologychemistryImmunologybiology.proteinFemaleNeurology (clinical)Geriatrics and GerontologyBiomarkersDevelopmental BiologyNeurobiology of aging
researchProduct

alpha-Glycerophosphocholine in the mental recovery of cerebral ischemic attacks. An Italian multicenter clinical trial.

1994

The clinical efficacy and the tolerability of alpha-glycerophosphocholine (alpha-GPC), a drug able to provide high levels of choline for the nervous cells of the brain and to protect their cell walls, have been tested in a clinical open multicenter trial on 2044 patients suffering from recent stroke or transient ischemic attacks. alpha-GPC was administered after the attack at the daily dose of 1000 mg im for 28 days and orally at the dose of 400 mg tid during the following 5 months after the first phase. The evaluation of the efficacy on the psychic recovery was done by the Mathew Scale (MS) during the period of im drug administration, and using the Mini Mental State Test (MMST), the Cricht…

MaleGeneral Biochemistry Genetics and Molecular BiologyBrain IschemiaHistory and Philosophy of ScienceRating scaleOral administrationMulticenter trialmedicineHumansCognitive declineAdverse effectStrokeAgedAged 80 and overbusiness.industryGeneral NeuroscienceDementia VascularHeartburnMiddle Agedmedicine.diseaseGlycerylphosphorylcholineTolerabilityAnesthesiaFemalemedicine.symptombusinessAnnals of the New York Academy of Sciences
researchProduct

Bilobalide, a constituent of Ginkgo biloba , inhibits NMDA-induced phospholipase A 2 activation and phospholipid breakdown in rat hippocampus

2000

In rat hippocampal slices superfused with magnesium-free buffer, glutamate (1 mM) caused the release of large amounts of choline due to phospholipid breakdown. This phenomenon was mimicked by N-methyl-D-aspartate (NMDA) in a calcium-sensitive manner and was blocked by NMDA receptor antagonists such as MK-801 and 7-chlorokynurenate. The NMDA-induced release of choline was not caused by activation of phospholipase D but was mediated by phospholipase A2 (PLA2) activation as the release of choline was accompanied by the formation of lyso-phosphatidylcholine (lyso-PC) and glycerophospho-choline (GPCh) and was blocked by 5-[2-(2-carboxyethyl)-4-dodecanoyl-3,5-dimethylpyrrol-1-yl]pentano ic acid, …

MaleMicrodialysisN-MethylaspartateMicrodialysisGlycineCyclopentanesPharmacologyHippocampal formationHippocampusReceptors N-Methyl-D-AspartatePhospholipases ACholinechemistry.chemical_compoundPhospholipase A2BilobalideSeizuresAnimalsCholineRats WistarFuransCells CulturedPhospholipidsPharmacologyPlants MedicinalDose-Response Relationship DrugbiologyPhospholipase DGlutamate receptorGinkgo bilobaLysophosphatidylcholinesGeneral MedicineGlycerylphosphorylcholineRatsEnzyme ActivationPhospholipases A2Ginkgolideschemistrybiology.proteinNMDA receptorDiterpenesNaunyn-Schmiedeberg's Archives of Pharmacology
researchProduct

A multicentre trial to evaluate the efficacy and tolerability of alpha-glycerylphosphorylcholine versus cytosine diphosphocholine in patients with va…

1991

An open clinical trial was carried out to compare the efficacy and the tolerability of 1 g/day α-glycerylphosphorylcholine (α-GPC) with 1 g/day cytosine diphosphocholine (CDP) both given intramuscularly for 90 days in 120 patients with mild to moderate vascular dementia. The clinical evaluation, carried out at the start as well as halfway through (45 days) and at the end of treatment (90 days), was expressed by psychometric tests (modified Parkside behaviour rating scale, Sandoz clinical assessment geriatric scale, word fluency test, Hamilton's rating scale of depression, narration subtest of Wechsler memory scale). Both treatments produced a definite symptomatic improvement and showed a v…

MaleWechsler Memory Scalemedicine.medical_specialtyCytidine Diphosphate Cholinemedicine.medical_treatment030204 cardiovascular system & hematologyBiochemistrylaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialRating scalelawInternal medicinemedicineDementiaHumansVascular dementiaAgedAged 80 and overPsychiatric Status Rating ScalesChemotherapybusiness.industryDementia VascularBiochemistry (medical)Cell BiologyGeneral MedicineDrug ToleranceMiddle Agedmedicine.diseaseGlycerylphosphorylcholineClinical trialTolerability030220 oncology & carcinogenesisAnesthesiaFemalebusinessThe Journal of international medical research
researchProduct

Unusual triskelion patterns and dye-labelled GUVs: consequences of the interaction of cholesterol-containing linear-hyperbranched block copolymers wi…

2015

Cholesterol (Ch) linked to a linear-hyperbranched block copolymer composed of poly(ethylene glycol) (PEG) and poly(glycerol) (hbPG) was investigated for its membrane anchoring properties. Two polyether-based linear-hyperbranched block copolymers with and without a covalently attached rhodamine fluorescence label (Rho) were employed (Ch-PEG30-b-hbPG23 and Ch-PEG30-b-hbPG17-Rho). Compression isotherms of co-spread 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) or 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) with the respective polymers were measured on the Langmuir trough and the morphology development of the liquid-condensed (LC) domains was studied by epi-fluorescence microsc…

PolymersPolyestersLipid BilayersPolyethylene GlycolsRhodaminechemistry.chemical_compoundMonolayerLactic AcidPOPCPhospholipidsUnilamellar Liposomeschemistry.chemical_classificationAqueous solutionChromatographyRhodaminesVesicletechnology industry and agricultureGeneral ChemistryPolymerCondensed Matter PhysicsGlycerylphosphorylcholineCrystallographyCholesterolMembraneMicroscopy FluorescencechemistryPhosphatidylcholineslipids (amino acids peptides and proteins)Ethylene glycolSoft Matter
researchProduct